EMBC
HEALTHCAREEmbecta Corp
Live · NASDAQ · May 9, Close
What's Moving EMBC Today?
No stock-specific AI insight has been generated for EMBC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.56
Fundamentals
Trading
EMBC News
21 articles- Embecta Corp. Reported A Surprise Loss, And Analysts Have Updated Their ForecastsYahoo Finance·May 8, 2026
- embecta to Participate at the 2026 BofA Securities Global Health Care ConferenceYahoo Finance·May 8, 2026
- Embecta Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:EMBC) 2026-05-07Seeking Alpha·May 7, 2026
- Embecta (EMBC): Do Buybacks Amid Losses Reveal Capital Discipline or Strategic Uncertainty?Yahoo Finance·May 6, 2026
- Why Embecta Stock Plummeted TodayThe Motley Fool·May 6, 2026
- Embecta Corp. Q2 2026 Earnings Call SummaryMoby·May 5, 2026
- Embecta (EMBC) Q2 2026 Earnings TranscriptMotley Fool·May 5, 2026
- Embecta Q2 Earnings Call HighlightsMarketbeat·May 5, 2026
- embecta Announces Quarterly Cash DividendYahoo Finance·May 5, 2026
- Embecta Corp. Reports Second Quarter Fiscal 2026 Financial ResultsYahoo Finance·May 5, 2026
- How The Embecta (EMBC) Story Is Shifting As Targets Trim While Fair Value HoldsYahoo Finance·Apr 30, 2026
- embecta to Report Fiscal Second Quarter Financial ResultsGlobeNewswire Inc.·Apr 21, 2026
- Is Embecta (EMBC) One of the 10 Healthcare Stocks with Highest Dividends?Yahoo Finance·Apr 17, 2026
- How The Embecta (EMBC) Investment Story Is Shifting As Fair Value And Expectations ResetYahoo Finance·Apr 15, 2026
- Should You Investigate Embecta Corp. (NASDAQ:EMBC) At US$8.88?Yahoo Finance·Apr 9, 2026
- Embecta to Acquire Owen Mumford to Expand Drug-Delivery PortfolioYahoo Finance·Mar 23, 2026
- Embecta agrees to acquire Owen MumfordMedicaldevice-network·Mar 20, 2026
- Embecta to buy Owen Mumford for up to $201MMedtechdive·Mar 19, 2026
- embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings LimitedYahoo Finance·Mar 19, 2026
- We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are UnderstatedYahoo Finance·Feb 12, 2026
- embecta names new Chairman of the Board and Lead Independent DirectorYahoo Finance·Feb 11, 2026
All 21 articles loaded
Price Data
52-Week Range
$3.56
Fundamentals
Trading
About Embecta Corp
Embecta Corp (EMBC) is a premier medical technology company specializing in innovative insulin delivery solutions for diabetes management. As a strategic spin-off from Becton, Dickinson and Company, Embecta utilizes state-of-the-art technologies and a diverse product portfolio, including insulin pens and syringes, to optimize patient care and improve health outcomes. With a strong commitment to operational excellence and a customer-centric approach, Embecta is well-positioned to seize growth opportunities in the rapidly evolving diabetes care market, aiming to enhance patient experiences while solidifying its leadership within the industry.